

Get the latest on the Baloxavir Marboxil (Xofluza) shortage in 2026. Learn what's causing it, when it may end, and how to get your flu treatment.
If you have been told your pharmacy is out of Baloxavir Marboxil (brand name Xofluza), you are experiencing what many patients across the country have dealt with during the 2025-2026 flu season. Availability of this popular single-dose flu treatment has been inconsistent, and patients are understandably frustrated.
This article gives you the latest information on the Baloxavir Marboxil shortage, explains what is causing it, and outlines what you can do to get treated as quickly as possible.
As of early 2026, Baloxavir Marboxil is not formally listed on the FDA's official drug shortage database. However, many pharmacies have reported intermittent stock-outs, especially during peak flu months (December through March). This means the drug is technically being manufactured and distributed, but demand is outpacing what is available on pharmacy shelves in many areas.
This type of shortage—where the drug exists but is hard to find locally—is sometimes called a "practical shortage" or "spot shortage." It is especially common with seasonal medications like Xofluza that see sudden demand spikes.
Several factors are contributing to the difficulty in finding Baloxavir Marboxil this flu season:
For a deeper dive into these factors, see our article on why Baloxavir Marboxil is so hard to find.
This is not the first time Xofluza has been difficult to find. Similar availability challenges occurred during the 2022-2023 and 2023-2024 flu seasons, when flu activity spiked and pharmacies ran low on stock. Each year, availability typically improves as flu season winds down in the spring.
Based on historical patterns, availability of Baloxavir Marboxil usually improves after flu season peaks, which is typically in late February or March. As fewer people get the flu, demand drops and pharmacies are able to restock. However, if a second wave of flu activity occurs later in the season, shortages could persist longer.
Genentech has not announced any long-term supply disruptions. The current challenges appear to be demand-driven rather than caused by manufacturing problems.
If you need Baloxavir Marboxil and cannot find it, take these steps:
To stay updated on the Baloxavir Marboxil shortage:
While dealing with medication availability is stressful, there are things you can do to protect yourself:
The Baloxavir Marboxil shortage in 2026 is driven mainly by seasonal demand, limited supply from a single manufacturer, and the drug's growing popularity. While it is not a formal FDA-listed shortage, real-world availability has been spotty. Use tools like MedFinder, call pharmacies proactively, and work with your doctor to find the best treatment option—whether that is Xofluza or an alternative. The most important thing is getting treated quickly.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.